Publication Name	World Journal of Gastroenterology
Manuscript ID	26653
Country	United States

Received	2016-04-20 10:49
Peer-Review Started	2016-04-21 11:27
To Make the First Decision	2016-05-27 14:57
Return for Revision	2016-05-28 13:46
Revised	2016-06-30 04:17
Second Decision	2016-07-18 09:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-08-01 15:28
Articles in Press	2016-08-01 15:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-08-25 13:39
Publish the Manuscript Online	2016-09-14 19:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Biomarkers for colitis-associated colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Ru Chen, Lisa A Lai, Teresa A Brentnall and Sheng Pan
Funding Agency and Grant Number	Funding Agency Grant Number NIH CA164548
Corresponding Author	Ru Chen, PhD, Department of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, United States. ruc@medicine.washington.edu
Key Words	Biomarker; Colitis; Dysplasia; Colorectal cancer; Surveillance; Progressor; Non-progressor
Core Tip	With the incidence of ulcerative colitis on the rise, there is a need to develop clinically useful biomarkers capable of identifying and monitoring the subset of ulcerative colitis (UC) patients at highest risk for developing colon cancer. Recent studies have reported the efforts in developing clinically relevant biomarkers, laying a foundation for further clinical biomarker development. While the challenge remains to validate these candidate biomarkers in multi-center studies using larger patient cohorts, it is certain that accurate biomarkers of colitis-associated neoplasia would improve current clinical management of neoplastic risk in UC patients.
Publish Date	2016-09-14 19:04
Citation	Chen R, Lai LA, Brentnall TA, Pan S. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol 2016; 22(35): 7882-7891
URL	http://www.wjgnet.com/1007-9327/full/v22/i35/7882.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i35.7882

Full Article (PDF)	WJG-22-7882.pdf
Full Article (Word)	WJG-22-7882.doc
Manuscript File	26653-Review.docx
Answering Reviewers	26653-Answering reviewers.pdf
Audio Core Tip	26653-Audio core tip.wma
Conflict-of-Interest Disclosure Form	26653-Conflict-of-interest statement.pdf
Copyright License Agreement	26653-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	26653-Grant application form(s).pdf
Peer-review Report	26653-Peer-review(s).pdf
Scientific Misconduct Check	26653-Scientific misconduct check.pdf
Scientific Editor Work List	26653-Scientific editor work list.pdf